Aspirin for Treatment of Multiple Sclerosis-Related Fatigue

NCT00467584 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

62

Enrollment

OTHER

Sponsor class

Stopped Interim analysis indicated treatment unlikely effective;slow recruitment

Conditions

Multiple Sclerosis
Fatigue

Interventions

DRUG: High Dose Aspirin (1300 mg/day)
DRUG: Low Dose Aspirin (162 mg/day)
DRUG: Placebo

Sponsor

Mayo Clinic

Collaborators

[object Object]